Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: Genflow Biosciences PLC Announces Presentation of Interim Results

(PR-inside.com) THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Presentation of Interim Results from SLAB Canine Study at the Animal Longevity Summit

LONDON, UK / ACCESS Newswire / October 5, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF), a biotechnology company developing gene therapies targeting the biology of ageing, ..

https://reports.pr-inside.com/genflow-b ... 230187.htm
Copyright PR-Inside.com 2026